Occlusion Devices Market worth USD 3.55 Billion by 2023
The global occlusion devices market was valued at USD 2.61 Billion in 2017 and is projected to reach USD 3.55 Billion by 2023 from, at a CAGR of 5.3%.
(businesspress24) - The global occlusion devices market was valued at USD 2.61 Billion in 2017 and is projected to reach USD 3.55 Billion by 2023 from, at a CAGR of 5.3%. Download a FREE Pdf Broucher
The Report Global Forecast to 2023"
In 2017, Boston Scientific (US), Medtronic (Ireland), Terumo Corporation (Japan), Stryker Corporation (US), and Penumbra (US) held the leading position in the global occlusion devices market. In the past three years, these companies adopted product developments & commercialization, acquisitions, market expansions, and agreements & collaborations as their key business strategies to ensure market dominance. Cardinal Health (US), Asahi Intecc (Japan), Avinger (US), B. Braun (Germany), and C.R. Bard (US) are some of the other major players in this market.
This report broadly segments the occlusion devices market into product, application, end user, and region. On the basis of product, the global market is segmented into occlusion removal devices (balloon occlusion devices, stent retrievers, coil retrievers, and suction and aspiration devices), embolization devices (embolic coils and liquid embolic agents), tubal occlusion devices, and support catheters (microcatheters and guidewires). In 2018, the occlusion removal devices segment is expected to account for the largest share of the market. This can be attributed to the increasing research activity to validate the clinical efficacy of novel occlusion removal devices (such as stent retrievers, coil retrievers, and balloon occlusion devices) and growing patient preference for minimally invasive surgeries.
Based on application, the market is categorized into neurology, cardiology, peripheral vascular diseases, urology, oncology, and gynecology. The neurology applications segment accounted for the largest share of the market in 2017. The increasing number of target neurosurgical procedures across major countries, growing research in the field of interventional neurology, strengthening research capabilities of major product manufacturers, and favorable reimbursement scenario for neurovascular surgeries across developed countries are the key factors supporting the growth of the occlusion devices market for neurology applications.
Based on end user, the market is segmented into three categories, namely, hospitals, diagnostic centers, and surgical centers; ambulatory care centers; and research laboratories & academic institutes. In 2018, the hospitals, diagnostic centers, and surgical centers segment is expected to account for the largest share of the market due to the growing adoption of minimally invasive surgical procedures, increasing purchasing power of major end users across developed countries, and the availability of reimbursements for target procedures in the US and major European countries.
To speak to our analyst for a discussion on the above findings, click: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=249840809
This report covers the market across four major regions, namely, North America, Europe, Asia Pacific, and RoW. North America is expected to command the largest share of the market in 2018.
Themen in dieser Pressemitteilung:
occlusion-devices-market-growth
occlusion-devices-market-share
occlusion-devices-market-size
occlusion-devices-market-trends
global-occlusion-devices-market
occlusion-devices-asia-pacific-market
occlusion-devices-europe-market
occlusion-devices-mar
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 10.06.2019 - 09:40 Uhr
Sprache: Deutsch
News-ID 1535350
Anzahl Zeichen: 3695
Kontakt-Informationen:
Ansprechpartner: Mr. Shelly Singh
Stadt:
northbrook
Telefon: 8886006441
Kategorie:
Vermischtes
Meldungsart: bitte
Versandart: Veröffentlichung
Freigabedatum:
Anmerkungen:
Diese Pressemitteilung wurde bisher 28 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Occlusion Devices Market worth USD 3.55 Billion by 2023
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
